A detailed history of Fayez Sarofim & CO transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 154,262 shares of WBA stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
154,262
Previous 128,508 20.04%
Holding current value
$1.39 Million
Previous $2.79 Million 33.05%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.1 - $19.54 $311,623 - $503,233
25,754 Added 20.04%
154,262 $1.87 Million
Q1 2024

May 14, 2024

SELL
$20.51 - $26.65 $188,076 - $244,380
-9,170 Reduced 6.66%
128,508 $2.79 Million
Q4 2023

Feb 14, 2024

SELL
$19.94 - $26.64 $593,992 - $793,578
-29,789 Reduced 17.79%
137,678 $3.59 Million
Q3 2023

Nov 14, 2023

SELL
$20.9 - $30.85 $594,396 - $877,374
-28,440 Reduced 14.52%
167,467 $3.72 Million
Q2 2023

Aug 14, 2023

SELL
$28.37 - $36.31 $3.87 Million - $4.95 Million
-136,329 Reduced 41.03%
195,907 $5.58 Million
Q1 2023

May 11, 2023

SELL
$32.33 - $37.71 $761,953 - $888,749
-23,568 Reduced 6.62%
332,236 $11.5 Million
Q4 2022

Feb 13, 2023

SELL
$30.52 - $41.79 $1.57 Million - $2.16 Million
-51,605 Reduced 12.67%
355,804 $13.3 Million
Q3 2022

Nov 14, 2022

SELL
$31.4 - $42.04 $3.66 Million - $4.9 Million
-116,504 Reduced 22.24%
407,409 $12.8 Million
Q2 2022

Aug 12, 2022

SELL
$37.9 - $46.81 $415,573 - $513,271
-10,965 Reduced 2.05%
523,913 $19.9 Million
Q1 2022

May 16, 2022

SELL
$44.77 - $54.33 $62,678 - $76,062
-1,400 Reduced 0.26%
534,878 $23.9 Million
Q4 2021

Feb 11, 2022

BUY
$43.72 - $52.25 $1.14 Million - $1.37 Million
26,181 Added 5.13%
536,278 $28 Million
Q3 2021

Nov 15, 2021

SELL
$45.58 - $51.78 $1.82 Million - $2.06 Million
-39,834 Reduced 7.24%
510,097 $24 Million
Q2 2021

Aug 13, 2021

SELL
$50.84 - $56.8 $1.03 Million - $1.15 Million
-20,194 Reduced 3.54%
549,931 $28.9 Million
Q1 2021

May 13, 2021

SELL
$41.16 - $55.05 $842,257 - $1.13 Million
-20,463 Reduced 3.46%
570,125 $31.3 Million
Q4 2020

Feb 11, 2021

SELL
$33.52 - $44.1 $863,508 - $1.14 Million
-25,761 Reduced 4.18%
590,588 $23.6 Million
Q3 2020

Nov 13, 2020

SELL
$34.67 - $43.16 $1.73 Million - $2.15 Million
-49,787 Reduced 7.47%
616,349 $22.1 Million
Q2 2020

Aug 11, 2020

SELL
$38.35 - $47.02 $1.18 Million - $1.45 Million
-30,871 Reduced 4.43%
666,136 $28.2 Million
Q1 2020

May 12, 2020

SELL
$41.02 - $59.59 $5.54 Million - $8.05 Million
-135,170 Reduced 16.24%
697,007 $31.9 Million
Q4 2019

Feb 14, 2020

SELL
$52.08 - $62.72 $8.94 Million - $10.8 Million
-171,704 Reduced 17.1%
832,177 $49.1 Million
Q3 2019

Nov 13, 2019

SELL
$49.29 - $58.06 $19.1 Million - $22.4 Million
-386,540 Reduced 27.8%
1,003,881 $55.5 Million
Q2 2019

Aug 09, 2019

SELL
$49.34 - $63.49 $8.38 Million - $10.8 Million
-169,882 Reduced 10.89%
1,390,421 $76 Million
Q1 2019

May 14, 2019

SELL
$59.79 - $74.43 $3.36 Million - $4.18 Million
-56,165 Reduced 3.47%
1,560,303 $98.7 Million
Q4 2018

Feb 13, 2019

SELL
$65.26 - $85.69 $5.98 Million - $7.86 Million
-91,676 Reduced 5.37%
1,616,468 $110 Million
Q3 2018

Nov 14, 2018

SELL
$60.76 - $73.81 $3.95 Million - $4.79 Million
-64,956 Reduced 3.66%
1,708,144 $125 Million
Q2 2018

Aug 14, 2018

SELL
$59.7 - $68.0 $8.37 Million - $9.53 Million
-140,167 Reduced 7.33%
1,773,100 $106 Million
Q1 2018

May 10, 2018

SELL
$65.43 - $80.27 $43.8 Million - $53.7 Million
-668,996 Reduced 25.91%
1,913,267 $125 Million
Q4 2017

Feb 13, 2018

SELL
$64.48 - $76.95 $8.44 Million - $10.1 Million
-130,862 Reduced 4.82%
2,582,263 $188 Million
Q3 2017

Nov 08, 2017

BUY
$77.22 - $82.74 $210 Million - $224 Million
2,713,125
2,713,125 $210 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $7.77B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.